Open access
Aug 2026
ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma
ERP44 is a prognostic biomarker that promotes LGG proliferation and TMZ resistance, suggesting its potential as a therapeutic target.
Ling-Min Shao, Jia Liu, Mohammad Rohul Amin et al.
· Cancer Genomics & Proteomics · 0 citations